Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.39NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.33 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.33 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.293NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.293NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.225NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.225NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.637NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.637NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.39 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.26 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.26 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.103 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.103 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-19737.6China
BA.1.14.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.14.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.14.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.14.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.17.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.17.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.99.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.99.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.15.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.15.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JD.1.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JD.1.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.441NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.441NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.509NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.509NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.14.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.14.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DY.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DY.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used